Publication | Open Access

The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens

Xrcc1 Genotype PolymorphismsMedicineGenetic EpidemiologyColorectal CancerPathologyCancer GenomicsIrinotecan-based RegimensCancer GeneticsOncologyRadiation OncologyClinical OutcomeCancer Research